Strata Critical Medical (SRTA) Asset Writedowns and Impairment (2023 - 2025)

Strata Critical Medical has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $1.7 million for Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment rose 129.05% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 70.06% YoY), while the FY2025 annual figure was $1.7 million, changed N/A from the prior year.
• Asset Writedowns and Impairment improved to $1.7 million in Q4 2025, from -$30000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for SRTA reached as high as $5.8 million in Q2 2024 and fell as low as -$5.8 million in Q4 2024.
• The 3-year median for Asset Writedowns and Impairment is $97000.0 (2023), against an average of $928000.0.
• Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment plunged 3633.13% — and 2025, when it jumped 129.05%.
• A 3-year view of Asset Writedowns and Impairment shows it stood at $163000.0 in 2023, then sank by 3633.13% to -$5.8 million in 2024, then jumped by 129.05% to $1.7 million in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $1.7 million, -$30000.0, and $30000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.